FAQ
Log In
Friday 2nd December 2016
News
 › 
 › 

Blair's pledge to industry

6th March 2007

The Prime Minister has reinforced his support of the UK pharmaceutical industry by announcing a top level study aimed at improving the country’s biotech activities.

It is hoped the wide-ranging review will strengthen the UK pharmaceutical and biotechnology sectors by examining how to increase funding and other incentives from the government and the City to enable smaller companies to grow.  The study is to be chaired by venture capitalist Sir David Cooksey who will look at issues such as the co-investment by public and private sectors in funding clinical trials.  It is hoped the review will be completed by the summer.

Mr Blair’s announcement came as he attended the launched of a £100m facility opened by Amgen, one of the world's largest biotech groups, in west London.  He used the event to outline his and his government’s continuing commitment to the UK’s pharmaceutical industry.  As part of his backing he pledged support for clinical studies, electronic patient records and stem cell research and also announced tough measures to clamp down on animal extremism. 

Speaking about the pharmaceutical and biotechnology sectors the Prime Minister said, “This is an industry whose profile is changing so fast that it is right to subject it to continued reassessment.  We've got a strong UK position. It's time for a new push for the industry. We've done a lot but the fact is we are in an increasingly competitive market.?


Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2016